Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Airway, Altimmune, Bavarian, Chinook, Genexine, Hibio, Hotspot, Humacyte, Maia, Moderna, Paradigm, Quadriga.

Biopharmas raising money in public or private financings, including: Araris, Eterna, Geneos, Immunebridge, Inflarx, Intrabio, Oncosec.

New hires and promotions in the biopharma industry, including: Aim, Arbor, Bausch + Lomb, Cellares, Century, Cue, Cybrexa, Dyve, Gennao, Invivyd, Kronos, Maplight, Mithra, Neuronascent, Northstar, Sonoma, Theravance, Totus, Viridian.

New hires and promotions in the biopharma industry in Asia-Pacific, including: ACM Biolabs, Biorchestra, Huidagene, Immutep, Kyowa Kirin.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Arrowhead, Bioarctic, Eisai, Geovax Labs, H. Lundbeck, Innocare, Lynk, Otsuka, Pardes, Takeda.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Arrowhead, Beactica, Dr. Reddy’s, Eagle, Evopoint, JCR, Karveer Meditech, Merck, Nanoviricides, Oscotec, Sumitomo, Takeda, Tonix.

Biopharmas in Asia-Pacific raising money in public or private financings: Cocrystal, Psyence, Recce.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Moximed, R2 Technologies, Reach Neuro.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Artera, Advanced Cooling, Attune Medical, Bone Biologics, Bristol Myers Squibb, Dermtech, Discovery Life Sciences, Foundation Medicine, Glooko, Hedia, Illumina, IMA Group, Neovasc, Reachbio Research, Shockwave Medical.

Med-tech firms raising money in public or private financings, including: Oshi Health, Sentiar.